compound introduction
BRD0209 is a potent, selective and dual inhibitor of GSK3α/β inhibitor (GSK3α IC 50 = 19 nM; GSK3β IC 50 = 5 nM). BRD0209 is also a reversible ATP-competitive inhibitor with fast-off kinetics ( K i = 4.2 nM, respectively). BRD0209 is a tricyclic pyrazolotetrahydroquinolinone compound. BRD0209 has the potential for the research of mood disorder diseases. Form:Solid
